Interstitial lung disease in SLE: a 30-year population study
Open Access
- 7 November 2025
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (2)
Abstract
Objectives: To compare incidence, risk factors and outcomes for interstitial lung disease (ILD) between patients with SLE and controls. Methods: We performed a population-level cohort study using state-wide longitudinal hospital data from Western Australia (WA) for patients with SLE (n = 1854, median age 40 years, 86% female) and matched hospitalized controls (n = 12107, median age 40 years, 88% female) over the period 1985–2014. We estimated ILD incidence rate (IR), determined independent risk factors for ILD using multivariate logistic regression and assessed outcomes including mortality rate (MR) and cause of death. Results presented as median, frequency, IR or MR per 1000 person years (PY) with 95% CIs and IR or MR ratios (IRR or MRR). Results: ILD occurred in 3.8% of SLE patients with a higher IR in SLE than the controls (3.11, 95% CI 2.44–3.91 vs 0.12, 95% CI 0.08–0.16; IRR 26.8) that was stable over time. Time to ILD from index was shorter in SLE and risk factors for ILD included older age, smoking and serositis. SLE-ILD patients experienced higher MRs (MR 52.0, 95% CI 37.0–71.1) than both SLE patients without ILD (MR 17.7, 95% CI 16.0–19.6; MRR 2.94) and controls with ILD (MR 22.8, 95% CI 12.1–38.9; MRR 2.28). ILD decreased survival for SLE and control cohorts and respiratory causes of death predominated in both the ILD groups. Conclusion: ILD occurred more frequently in SLE than the controls with older age, smoking and serositis as risk factors. As SLE-ILD adversely impacts prognosis with increased mortality, greater awareness and earlier management is warranted.Keywords
Funding Information
- The Arthritis Foundation of Western Australia
This publication has 32 references indexed in Scilit:
- Predicting and validating the risk of interstitial lung disease in systemic lupus erythematosusInternational Journal of Medical Informatics, 2025
- A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD studyScandinavian Journal of Rheumatology, 2024
- Mortality and causes of death in systemic lupus erythematosus over the last decade: Data from a large population-based studyEuropean Journal of Internal Medicine, 2023
- Validation of diagnostic coding for interstitial lung diseases in an electronic health record system in Hong KongPharmacoepidemiology and Drug Safety, 2022
- Risk of interstitial lung disease in patients with newly diagnosed systemic autoimmune rheumatic disease: A nationwide, population-based cohort studySeminars in Arthritis and Rheumatism, 2020
- Validation of claims-based algorithms to identify interstitial lung disease in patients with rheumatoid arthritisSeminars in Arthritis and Rheumatism, 2020
- Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre studyScientific Reports, 2019
- A systematic review of validated methods for identifying pulmonary fibrosis and interstitial lung disease using administrative and claims dataPharmacoepidemiology and Drug Safety, 2012
- Association of the Charlson comorbidity index with mortality in systemic lupus erythematosusArthritis Care & Research, 2011
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 CountriesAmerican Journal of Epidemiology, 2011